We are live on ! Find out more
EU

Emory University Portfolio holdings

AUM $267M
1-Year Est. Return 48.26%
This Fund
S&P 500
This Quarter Est. Return
-4.98%
1 Year Est. Return
+48.26%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$50.7M
AUM Growth
-$91.4M
Cap. Flow
-$87.1M
Cap. Flow %
-171.69%
Top 10 Hldgs %
89.73%
Holding
46
New
–
Increased
–
Reduced
17
Closed
27

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
JD icon
JD.com
JD
+$12M
2
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$5.26M
3
ARRY
Array Biopharma Inc
ARRY
+$4.01M
4
IOVA icon
Iovance Biotherapeutics
IOVA
+$3.21M
5
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$3.16M

Sector Composition

Rank Sector Weight
1 Financials 61.49%
2 Healthcare 34.13%
3 Industrials 1.88%
4 Energy 0.67%
5 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRK.A icon
1
Berkshire Hathaway Class A
BRK.A
$1.06T
$31.2M 61.49%
100
-17
-15% -$5.26M
EIDX
2
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$2.44M 4.81%
67,753
-16,083
-19% -$628K
THOR
3
DELISTED
Synthorx, Inc. Common Stock
THOR
$2.36M 4.66%
145,150
-5,898
-4% -$98.7K
WVE icon
4
Wave Life Sciences
WVE
$1.12B
$1.61M 3.17%
78,212
-16,263
-17% -$373K
RYTM icon
5
Rhythm Pharmaceuticals
RYTM
$7.31B
$1.55M 3.06%
71,856
-14,352
-17% -$308K
RARX
6
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$1.41M 2.78%
59,690
-38,226
-39% -$1.13M
BCRX icon
7
BioCryst Pharmaceuticals
BCRX
$2.36B
$1.38M 2.71%
479,902
-165,681
-26% -$515K
MGTX icon
8
MeiraGTx Holdings
MGTX
$1.15B
$1.29M 2.55%
81,176
-14,286
-15% -$332K
ORTX
9
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$1.29M 2.55%
10,869
-1,471
-12% -$205K
ZGNX
10
DELISTED
Zogenix, Inc.
ZGNX
$997K 1.97%
24,890
-35,015
-58% -$1.61M
ACA icon
11
Arcosa
ACA
$7.12B
$955K 1.88%
27,923
-24,341
-47% -$843K
HRTX icon
12
Heron Therapeutics
HRTX
$89.1M
$925K 1.82%
49,974
-79,046
-61% -$1.45M
TVTX icon
13
Travere Therapeutics
TVTX
$5.27B
$895K 1.76%
77,180
-46,420
-38% -$767K
MYOV
14
DELISTED
Myovant Sciences Ltd.
MYOV
$762K 1.5%
146,475
-31,513
-18% -$234K
GHDX
15
DELISTED
Genomic Health, Inc.
GHDX
$645K 1.27%
9,506
-33,460
-78% -$2.3M
SMC
16
Summit Midstream
SMC
$407M
$342K 0.67%
4,697
-1,140
-20% -$105K
COCP icon
17
Cocrystal Pharma
COCP
$13.1M
$312K 0.62%
12,743
– –
SPY icon
18
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$280K 0.55%
942
– –
IFRX icon
19
InflaRx
IFRX
$272M
$91K 0.18%
36,818
-21,631
-37% -$62.9K
ACAD icon
20
Acadia Pharmaceuticals
ACAD
$4.38B
– –
-90,188
Closed -$2.41M
AMRN
21
Amarin Corp
AMRN
$292M
– –
-6,613
Closed -$2.56M
ASND icon
22
Ascendis Pharma A/S
ASND
$17.1B
– –
-18,334
Closed -$2.11M
BFH icon
23
Bread Financial
BFH
$4.01B
– –
-16,324
Closed -$1.83M
BHC icon
24
Bausch Health
BHC
$1.8B
– –
-78,121
Closed -$1.97M
BMRN icon
25
BioMarin Pharmaceuticals
BMRN
$11.5B
– –
-26,278
Closed -$2.25M
1
2

Similar funds

CFG
Cambridge Financial Group Columbus, Ohio $267M AUM 31.62% 1-Year Est. Return
PC
Packer & Co Cottesloe, Australia $267M AUM
ALC
Alexander Labrunerie & Co Columbia, Missouri $267M AUM 21.24% 1-Year Est. Return
TWM
TCFG Wealth Management Laguna Niguel, California $267M AUM 39.78% 1-Year Est. Return
IP
Indigo Partners Phoenix, Arizona $267M AUM 9% 1-Year Est. Return
SP
ShawSpring Partners Boston, Massachusetts $268M AUM 28.19% 1-Year Est. Return
EAIC
Empower Annuity Insurance Company Hartford, Connecticut $268M AUM 0.28% 1-Year Est. Return
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

Emory University's Q3 2019 Portfolio in Review

As of Q3 2019, Emory University held 46 positions worth $50.7M, down 64% from $142M the previous quarter. Its ten largest holdings account for 90% of the portfolio.

Emory University withdrew a net $87.1M in Q3 2019, closing 27 positions and reducing 17 holdings. Its most notable exit was JD.com, an estimated $12M position sold in full.

By sector, the portfolio is most concentrated in Financials at 61% of assets, up from 33% a quarter earlier, followed by Healthcare and Industrials.

  • Emory University's biggest Q3 2019 reduction was Berkshire Hathaway Class A, cutting an estimated $5.26M.
  • Emory University fully exited JD.com in Q3 2019, selling an estimated $12M.
  • Emory University's ten largest holdings make up 90% of its $50.7M portfolio in Q3 2019.
  • Emory University opened 0 new positions and closed 27 in Q3 2019.
  • Emory University's portfolio value fell 64% quarter-over-quarter to $50.7M.

Based on Emory University's 13F filing for Q3 2019, filed 14 Nov 2019.